TECENTRIQ (ATEZOLIZUMAB)


GENENTECH, INC.
  • HR negative, HEr2 negative, Pd-l1 positive breast cancer
  • Non-small cell lung cancer
  • Small cell lung carcinoma
  • Transitional cell carcinoma of the urinary tract